Admetsys' FDA Breakthrough Designation Accelerates Arrival of Fully Autonomous Clinical Robotics in Hospital
Posted:
Admetsys Corporation, a biomedical technology company specializing in critical care automation, announced today that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
See the difference in patient outcomes!
Contact Restorative Therapies Inc today to learn about how Xcite2 can help your patients' recovery journeys!
#RestorativeTherapies #Xcite2 #FES #Innovation
Consistently appearing among the top ten causes of years lived with disability across all WHO regions - it is responsible for 14.3% of deaths worldwide, translating to approximately 8 million lives lost each year.
This urgent demand highlights a significant shortage…
Attendees
Sponsors and
Exhibitors
Webinars
Contact us